Department of Intensive Care Medicine, Ballarat Health Services, Ballarat, Victoria, Australia.
Department of Intensive Care Medicine, Peninsula Health, Frankston, Victoria, Australia.
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66. doi: 10.1164/rccm.202006-2405OC.
Initial reports of case fatality rates (CFRs) among adults with coronavirus disease (COVID-19) receiving invasive mechanical ventilation (IMV) are highly variable. To examine the CFR of patients with COVID-19 receiving IMV. Two authors independently searched PubMed, Embase, medRxiv, bioRxiv, the COVID-19 living systematic review, and national registry databases. The primary outcome was the "reported CFR" for patients with confirmed COVID-19 requiring IMV. "Definitive hospital CFR" for patients with outcomes at hospital discharge was also investigated. Finally, CFR was analyzed by patient age, geographic region, and study quality on the basis of the Newcastle-Ottawa Scale. Sixty-nine studies were included, describing 57,420 adult patients with COVID-19 who received IMV. Overall reported CFR was estimated as 45% (95% confidence interval [CI], 39-52%). Fifty-four of 69 studies stated whether hospital outcomes were available but provided a definitive hospital outcome on only 13,120 (22.8%) of the total IMV patient population. Among studies in which age-stratified CFR was available, pooled CFR estimates ranged from 47.9% (95% CI, 46.4-49.4%) in younger patients (age ≤40 yr) to 84.4% (95% CI, 83.3-85.4%) in older patients (age >80 yr). CFR was also higher in early COVID-19 epicenters. Overall heterogeneity is high ( >90%), with nonsignificant Egger's regression test suggesting no publication bias. Almost half of patients with COVID-19 receiving IMV died based on the reported CFR, but variable CFR reporting methods resulted in a wide range of CFRs between studies. The reported CFR was higher in older patients and in early pandemic epicenters, which may be influenced by limited ICU resources. Reporting of definitive outcomes on all patients would facilitate comparisons between studies.Systematic review registered with PROSPERO (CRD42020186997).
初始报告显示,接受有创机械通气(IMV)的冠状病毒病(COVID-19)成年患者的病死率(CFR)差异很大。为了研究接受 IMV 的 COVID-19 患者的 CFR,两位作者独立检索了 PubMed、Embase、medRxiv、bioRxiv、COVID-19 活系统综述和国家登记数据库。主要结局是接受 IMV 的确诊 COVID-19 患者的“报告 CFR”。还研究了出院时患者的“确定医院 CFR”。最后,根据纽卡斯尔-渥太华量表,按患者年龄、地理位置和研究质量分析 CFR。纳入了 69 项研究,描述了 57420 例接受 IMV 的成年 COVID-19 患者。总体报告的 CFR 估计为 45%(95%置信区间[CI],39-52%)。69 项研究中有 54 项表明是否可以获得医院结果,但仅在总共 13120 例(22.8%)接受 IMV 的患者人群中提供了明确的医院结果。在提供年龄分层 CFR 的研究中,汇总的 CFR 估计值范围从年轻患者(年龄≤40 岁)的 47.9%(95%CI,46.4-49.4%)到老年患者(年龄>80 岁)的 84.4%(95%CI,83.3-85.4%)。在 COVID-19 早期流行中心,CFR 也较高。总体异质性很高(>90%),Egger 回归检验无显著性,表明无发表偏倚。根据报告的 CFR,接受 IMV 的 COVID-19 患者中近一半死亡,但 CFR 报告方法的差异导致研究之间的 CFR 范围很广。在老年患者和大流行早期流行中心,报告的 CFR 更高,这可能受到 ICU 资源有限的影响。报告所有患者的明确结局将有助于研究之间的比较。系统评价在 PROSPERO(CRD42020186997)中注册。